Skip to main content

Peer Review reports

From: Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability

Original Submission
2 Sep 2015 Submitted Original manuscript
6 Dec 2015 Reviewed Reviewer Report - Tariq Javed
4 Feb 2016 Reviewed Reviewer Report - Paul J. Rowan
25 Mar 2016 Author responded Author comments - Giulia Malaguarnera
Resubmission - Version 2
25 Mar 2016 Submitted Manuscript version 2
18 Apr 2016 Reviewed Reviewer Report - Tariq Javed
6 May 2016 Reviewed Reviewer Report - Eric Dieperink
22 Jun 2016 Author responded Author comments - Giulia Malaguarnera
Resubmission - Version 3
22 Jun 2016 Submitted Manuscript version 3
28 Jun 2016 Reviewed Reviewer Report - Eric Dieperink
31 Aug 2016 Author responded Author comments - Giulia Malaguarnera
Resubmission - Version 4
31 Aug 2016 Submitted Manuscript version 4
5 Oct 2016 Author responded Author comments - Giulia Malaguarnera
Resubmission - Version 5
5 Oct 2016 Submitted Manuscript version 5
27 Oct 2016 Author responded Author comments - Giulia Malaguarnera
Resubmission - Version 6
27 Oct 2016 Submitted Manuscript version 6
Publishing
7 Nov 2016 Editorially accepted
15 Nov 2016 Article published 10.1186/s12888-016-1115-z

You can find further information about peer review here.

Back to article page